Westmount Partners’s Boston Scientific BSX Stock Holding History

Westmount Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,223	Closed	-$212K	–	268
2025 Q4	$212K	Sell	2,223 -416	-16%	-$40.8K	0.05%	236
2025 Q3	$253K	Hold	2,639	–	–	0.07%	217
2025 Q2	$283K	Buy	2,639 +33	+1%	+$3.34K	0.08%	201
2025 Q1	$263K	Buy	+2,606	New	+$262K	0.08%	204

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Westmount Partners's BSX Position: Q1 2026 in Review

Westmount Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 2,223 shares — an estimated $212K sold.

Westmount Partners first reported a position in BSX in Q1 2025 and held it in 4 quarters. The position peaked at $283K in Q2 2025. 1,676 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Westmount Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Westmount Partners sold 2,223 Boston Scientific shares in Q1 2026, an estimated $212K.
Westmount Partners first reported a position in Boston Scientific in Q1 2025 and held it in 4 quarters.
Westmount Partners's Boston Scientific position peaked at $283K in Q2 2025.
1,676 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Westmount Partners's 13F filing for Q1 2026, filed 16 Apr 2026.